Barré syndrome, although it said data don’t prove a causal link and affirmed the shots’ benefit outweighs their risks.
A post-marketing review by the FDA detected an increased risk of the autoimmune condition in patients inoculated with GSK’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback